Literature DB >> 33613533

Role of the NLRP3 Inflammasome: Insights Into Cancer Hallmarks.

Ting-Yi Lin1, Meng-Chun Tsai1, Wei Tu1, Hsin-Chih Yeh1,2,3,4, Shu-Chi Wang5, Shu-Pin Huang2,4,6,7, Chia-Yang Li6,7,8.   

Abstract

In response to a variety of stresses, mammalian cells activate the inflammasome for targeted caspase-dependent pyroptosis. The research community has recently begun to deduce that the activation of inflammasome is instigated by several known oncogenic stresses and metabolic perturbations; nevertheless, the role of inflammasomes in the context of cancer biology is less understood. In manipulating the expression of inflammasome, researchers have found that NLRP3 serves as a deterministic player in conducting tumor fate decisions. Understanding the mechanistic underpinning of pro-tumorigenic and anti-tumorigenic pathways might elucidate novel therapeutic onco-targets, thereby providing new opportunities to manipulate inflammasome in augmenting the anti-tumorigenic activity to prevent tumor expansion and achieve metastatic control. Accordingly, this review aims to decode the complexity of NLRP3, whereby summarizing and clustering findings into cancer hallmarks and tissue contexts may expedite consensus and underscore the potential of the inflammasome in drug translation.
Copyright © 2021 Lin, Tsai, Tu, Yeh, Wang, Huang and Li.

Entities:  

Keywords:  NLRP3 inflammasome; cancer hallmarks; interleukin-1β; pyroptosis; tumor microenvironment

Year:  2021        PMID: 33613533      PMCID: PMC7886802          DOI: 10.3389/fimmu.2020.610492

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  108 in total

1.  Nuclear DNA damage-triggered NLRP3 inflammasome activation promotes UVB-induced inflammatory responses in human keratinocytes.

Authors:  Tatsuya Hasegawa; Masaya Nakashima; Yoshiharu Suzuki
Journal:  Biochem Biophys Res Commun       Date:  2016-06-23       Impact factor: 3.575

Review 2.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

3.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization.

Authors:  Veit Hornung; Franz Bauernfeind; Annett Halle; Eivind O Samstad; Hajime Kono; Kenneth L Rock; Katherine A Fitzgerald; Eicke Latz
Journal:  Nat Immunol       Date:  2008-07-11       Impact factor: 25.606

4.  Cancer cells induce interleukin-22 production from memory CD4+ T cells via interleukin-1 to promote tumor growth.

Authors:  Cornelia Voigt; Peter May; Adrian Gottschlich; Anamarija Markota; Daniel Wenk; Inga Gerlach; Sebastian Voigt; Georgios T Stathopoulos; Kristina A M Arendt; Constanze Heise; Felicitas Rataj; Klaus-Peter Janssen; Melanie Königshoff; Hauke Winter; Isabelle Himsl; Wolfgang E Thasler; Max Schnurr; Simon Rothenfußer; Stefan Endres; Sebastian Kobold
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-17       Impact factor: 11.205

5.  Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro.

Authors:  F Vidal-Vanaclocha; A Alvarez; A Asumendi; B Urcelay; P Tonino; C A Dinarello
Journal:  J Natl Cancer Inst       Date:  1996-02-21       Impact factor: 13.506

Review 6.  Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer.

Authors:  Kimberly M Arnold; Lynn M Opdenaker; Daniel Flynn; Jennifer Sims-Mourtada
Journal:  Cancer Growth Metastasis       Date:  2015-01-29

7.  NLRP3 inflammasome inactivation driven by miR‑223‑3p reduces tumor growth and increases anticancer immunity in breast cancer.

Authors:  Liping Zhang; Hongzhi Li; Yuwei Zang; Feng Wang
Journal:  Mol Med Rep       Date:  2019-01-23       Impact factor: 2.952

Review 8.  The inflammasome: an emerging therapeutic oncotarget for cancer prevention.

Authors:  Wang Zhiyu; Neng Wang; Qi Wang; Cheng Peng; Jin Zhang; Pengxi Liu; Aihua Ou; Shaowen Zhong; Mario D Cordero; Yi Lin
Journal:  Oncotarget       Date:  2016-08-02

9.  Globular Adiponectin Inhibits Breast Cancer Cell Growth through Modulation of Inflammasome Activation: Critical Role of Sestrin2 and AMPK Signaling.

Authors:  Duc-Vinh Pham; Pawan Kumar Raut; Mahesh Pandit; Jae-Hoon Chang; Nikita Katila; Dong-Young Choi; Jee-Heon Jeong; Pil-Hoon Park
Journal:  Cancers (Basel)       Date:  2020-03-06       Impact factor: 6.639

10.  Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death.

Authors:  Erica Salaro; Alessia Rambaldi; Simonetta Falzoni; Francesca Saveria Amoroso; Alessia Franceschini; Alba Clara Sarti; Massimo Bonora; Francesco Cavazzini; Gian Matteo Rigolin; Maria Ciccone; Valentina Audrito; Silvia Deaglio; Pablo Pelegrin; Paolo Pinton; Antonio Cuneo; Francesco Di Virgilio
Journal:  Sci Rep       Date:  2016-05-25       Impact factor: 4.379

View more
  7 in total

1.  IL-1 receptor-associated kinase 1 participates in the modulation of the NLRP3 inflammasome by tumor-associated macrophages in hepatocellular carcinoma.

Authors:  Wei Chen; Mingjuan Hu; Tao Wei; Ying Liu; Tian Tan; Chengfang Zhang; Jiaxuan Weng
Journal:  J Gastrointest Oncol       Date:  2022-06

Review 2.  Extracellular Vesicles and the Inflammasome: An Intricate Network Sustaining Chemoresistance.

Authors:  Letizia Mezzasoma; Ilaria Bellezza; Rita Romani; Vincenzo Nicola Talesa
Journal:  Front Oncol       Date:  2022-04-22       Impact factor: 5.738

3.  NLRP3 activation in tumor-associated macrophages enhances lung metastasis of pancreatic ductal adenocarcinoma.

Authors:  Haitao Gu; Wensheng Deng; Yi Zhang; Yu Chang; Vishal G Shelat; Kunihiro Tsuchida; Leonardo S Lino-Silva; Zhaowen Wang
Journal:  Transl Lung Cancer Res       Date:  2022-05

Review 4.  Glioblastoma as an age-related neurological disorder in adults.

Authors:  Miri Kim; Erik Ladomersky; Andreas Mozny; Masha Kocherginsky; Kaitlyn O'Shea; Zachary Z Reinstein; Lijie Zhai; April Bell; Kristen L Lauing; Lakshmi Bollu; Erik Rabin; Karan Dixit; Priya Kumthekar; Leonidas C Platanias; Lifang Hou; Yinan Zheng; Jennifer Wu; Bin Zhang; Maya Hrachova; Sarah A Merrill; Maciej M Mrugala; Vikram C Prabhu; Craig Horbinski; Charles David James; Bakhtiar Yamini; Quinn T Ostrom; Margaret O Johnson; David A Reardon; Rimas V Lukas; Derek A Wainwright
Journal:  Neurooncol Adv       Date:  2021-09-04

5.  A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma.

Authors:  Jiahang Song; Yuanyuan Sun; Hui Cao; Zhengcheng Liu; Lei Xi; Changqing Dong; Rusong Yang; Ye Shi
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  Inhibition of NLRP3 by Fermented Quercetin Decreases Resistin-Induced Chemoresistance to 5-Fluorouracil in Human Colorectal Cancer Cells.

Authors:  Ko-Chao Lee; Kuen-Lin Wu; Chia-Kung Yen; Shun-Fu Chang; Cheng-Nan Chen; Ying-Chen Lu
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-27

7.  Natriuretic Peptides Regulate Prostate Cells Inflammatory Behavior: Potential Novel Anticancer Agents for Prostate Cancer.

Authors:  Letizia Mezzasoma; Vincenzo Nicola Talesa; Egidia Costanzi; Ilaria Bellezza
Journal:  Biomolecules       Date:  2021-05-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.